Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+ Gastric Cancer Patient: Case Report

Trastuzumab, has played a major role in improving treatment outcomes in HER-2 positive gastric cancer. However, once there is disease progression there is a paucity of evidence for second line therapy. Patient-derived xenografts (PDXs) in combination with liquid biopsies can help guide individual th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Aguilar-Mahecha, Adriana, Joseph, Sarah, Cavallone, Luca, Buchanan, Marguerite, Krzemien, Urszula, Batist, Gerald, Basik, Mark
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691136/
https://ncbi.nlm.nih.gov/pubmed/31448226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00698
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky